Short Communication - (2025) Volume 13, Issue 2
Received: 01-Apr-2025, Manuscript No. JCMG-25-165757;
Editor assigned: 03-Apr-2025, Pre QC No. P-165757;
Reviewed: 17-Apr-2025, QC No. Q-165757;
Revised: 22-Apr-2025, Manuscript No. R-165757;
Published:
29-Apr-2025
, DOI: 10.37421/2472-128X.2025.13.327
Citation: Noor, Lerner. “Revisiting the Concept of Heritability in the Genomic Era: From Twin Studies to Polygenic Scores.” J Clin Med Genomics 13 (2025): 327.
Copyright: © 2025 Noor L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The concept of heritability has long been a cornerstone in the field of genetics, offering insights into the role of genetic factors in shaping phenotypic traits. Traditional approaches to understanding heritability have relied heavily on twin studies, a method that has provided key insights into the genetic and environmental contributions to complex traits and diseases. Twin studies, based on the comparison of identical and fraternal twins, have allowed researchers to disentangle the relative contributions of genes and the environment to individual differences. This classical approach to studying heritability, while foundational, is increasingly being challenged and refined in the genomic era, as advances in high-throughput sequencing technologies and computational genomics provide more nuanced and powerful tools for investigating the genetic architecture of complex traits. With the advent of polygenic scores-composite measures that aggregate the effects of many genetic variants across the genome-the landscape of heritability research has shifted, offering new ways to explore the genetic basis of diseases and traits. In this context, revisiting the concept of heritability is critical for understanding the implications of recent genomic advances for both basic and applied genetics [1].
Historically, the concept of heritability has been understood as a proportion of the variation in a trait that can be attributed to genetic factors. In twin studies, this was quantified by comparing the phenotypic similarity between identical (monozygotic) and fraternal (dizygotic) twins. Identical twins, who share 100% of their genetic material, are expected to be more similar to one another in terms of traits like height, intelligence, or susceptibility to diseases, compared to fraternal twins who share only 50% of their genetic material. By assessing the differences in similarity between these two groups of twins, researchers could estimate the heritability of a given trait, offering important insights into how much of the variation in that trait could be explained by genetic differences. The classic heritability estimate, which ranges from 0 to 1, reflects the proportion of phenotypic variance that is attributable to genetic factors, with higher values suggesting a greater genetic influence [2].
While twin studies provided a powerful method for estimating the heritability of various traits, they were not without limitations. One major limitation is the assumption that environmental factors are shared equally between identical and fraternal twins, which may not always be the case. For example, identical twins are often treated more similarly by their parents, friends, and society, which could introduce biases in the estimation of heritability. Furthermore, twin studies are typically limited by the sample sizes available, particularly for rare traits or diseases, and are often constrained to studying relatively simple, binary traits rather than complex diseases with multifactorial causes. Despite these limitations, twin studies remained the dominant tool for understanding heritability for much of the 20th century [3].
The emergence of high-throughput genomic technologies, such as next-generation sequencing and Genome-Wide Association Studies (GWAS), has dramatically reshaped our understanding of the genetic basis of complex traits [4]. Unlike the relatively simple approach of twin studies, which focused on a few variables, GWAS involves scanning the entire genome for common genetic variants (single nucleotide polymorphisms, or SNPs) that are associated with particular traits or diseases. By identifying genetic variants that contribute to the risk of disease or variation in a particular trait, GWAS has uncovered hundreds of thousands of genetic loci linked to conditions such as cardiovascular disease, diabetes, and mental health disorders. These studies have provided a more detailed and precise picture of the genetic underpinnings of complex traits, allowing for the identification of specific genes and regulatory regions that may not have been detectable using twin study methods [5].
None.
None.
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report